Education
About Us
Working with TipRanks
Follow Us
Curative Biotechnology (CUBT)
OTHER OTC:CUBT
Total Valuation
Curative Biotechnology has a market cap or net worth of $7.31M. The enterprise value is $10.44M.
Market Cap$7.31M
Enterprise Value$10.44M
Share Statistics
Curative Biotechnology has 1,012,763,370 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding1,012,763,370
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Curative Biotechnology’s return on equity (ROE) is 0.73 and return on invested capital (ROIC) is 68.88%.
Return on Equity (ROE)0.73
Return on Assets (ROA)-1.65
Return on Invested Capital (ROIC)68.88%
Return on Capital Employed (ROCE)0.50
Revenue Per Employee0.00
Profits Per Employee-891.22K
Employee Count4
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Curative Biotechnology is ―. Curative Biotechnology’s PEG ratio is 0.06.
PE Ratio―
PS Ratio0.00
PB Ratio-2.37
Price to Fair Value-2.37
Price to FCF-11.36
Price to Operating Cash Flow-7.64
PEG Ratio0.06
Income Statement
In the last 12 months, Curative Biotechnology had revenue of 0.00 and earned -3.56M in profits. Earnings per share was 0.00.
Revenue0.00
Gross Profit-92.21K
Operating Income-2.44M
Pretax Income-3.56M
Net Income-3.56M
EBITDA-2.35M
Earnings Per Share (EPS)0.00
Cash Flow
In the last 12 months, operating cash flow was -1.12M and capital expenditures -3.00, giving a free cash flow of -1.12M billion.
Operating Cash Flow-1.12M
Free Cash Flow-1.12M
Free Cash Flow per Share>-0.01
Dividends & Yields
Curative Biotechnology pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.42
52-Week Price Change-50.00%
50-Day Moving Average0.01
200-Day Moving Average0.01
Relative Strength Index (RSI)47.47
Average Volume (3m)181.23K
Important Dates
Curative Biotechnology upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
Curative Biotechnology as a current ratio of 0.03, with Debt / Equity ratio of -62.21%
Current Ratio0.03
Quick Ratio0.03
Debt to Market Cap0.12
Net Debt to EBITDA-0.57
Interest Coverage Ratio-2.17
Taxes
In the past 12 months, Curative Biotechnology has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Curative Biotechnology EV to EBITDA ratio is -5.52, with an EV/FCF ratio of -12.68.
EV to Sales0.00
EV to EBITDA-5.52
EV to Free Cash Flow-12.68
EV to Operating Cash Flow-12.68
Balance Sheet
Curative Biotechnology has $218.26K in cash and marketable securities with $3.11M in debt, giving a net cash position of -$2.89M billion.
Cash & Marketable Securities$218.26K
Total Debt$3.11M
Net Cash-$2.89M
Net Cash Per Share>-$0.01
Tangible Book Value Per Share>-$0.01
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Curative Biotechnology is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―